Search research articles
Contact Us
Filters
Showing results (351-360 of 363) with videos related to
Page
of 37
Sort By:
Leukemia
|
December 17, 2009
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
A Möricke, M Zimmermann, A Reiter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86
M Paulussen, S Ahrens, J Dunst, et al.
Blood
|
February 9, 2000
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation
C Zeidler, K Welte, Y Barak, et al.
Medical and Pediatric Oncology
|
September 1, 1997
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society
B E Favara, A C Feller, M Pauli, et al.
The Journal of Biological Chemistry
|
March 21, 1997
Molecular and functional characterization of the urokinase receptor on human mast cells
C Sillaber, M Baghestanian, R Hofbauer, et al.
Pediatric Blood & Cancer
|
June 6, 2013
Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria
C Rossig, H Juergens, M Schrappe, et al.
Klinische Padiatrie
|
May 24, 2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000
M Schrappe, A Möricke, A Reiter, et al.
Blood
|
August 10, 1999
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991)
W A Kamps, J P Bökkerink, K Hählen, et al.
Leukemia
|
February 2, 2008
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
T Flohr, A Schrauder, G Cazzaniga, et al.
Klinische Padiatrie
|
July 1, 1982
[Acute lymphoblastic leukemia therapy study BFM 79/81 in children and adolescents: intensified reinduction therapy for patients with different risk for relapse]
G Henze, H J Langermann, R Fengler, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 363) with videos related to
Sort By:
Page
of 37
Leukemia
|
December 17, 2009
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
A Möricke, M Zimmermann, A Reiter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86
M Paulussen, S Ahrens, J Dunst, et al.
Blood
|
February 9, 2000
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation
C Zeidler, K Welte, Y Barak, et al.
Medical and Pediatric Oncology
|
September 1, 1997
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society
B E Favara, A C Feller, M Pauli, et al.
The Journal of Biological Chemistry
|
March 21, 1997
Molecular and functional characterization of the urokinase receptor on human mast cells
C Sillaber, M Baghestanian, R Hofbauer, et al.
Pediatric Blood & Cancer
|
June 6, 2013
Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria
C Rossig, H Juergens, M Schrappe, et al.
Klinische Padiatrie
|
May 24, 2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000
M Schrappe, A Möricke, A Reiter, et al.
Blood
|
August 10, 1999
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991)
W A Kamps, J P Bökkerink, K Hählen, et al.
Leukemia
|
February 2, 2008
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
T Flohr, A Schrauder, G Cazzaniga, et al.
Klinische Padiatrie
|
July 1, 1982
[Acute lymphoblastic leukemia therapy study BFM 79/81 in children and adolescents: intensified reinduction therapy for patients with different risk for relapse]
G Henze, H J Langermann, R Fengler, et al.
Page
of 37